Jonathan A. Harounian

Jonathan Harounian practices at Island Hearing & Balance Center in Levittown, New York.

Jonathan Harounian's NPI, 1386039196, was assigned on March 30, 2015. Jonathan Harounian holds New York license 309676.

Jonathan Harounian's primary practice is Island Hearing & Balance Center, at 2870 Hempstead Tpke, Levittown, NY 11756. The practice phone is (516) 731-6644.

Jonathan Harounian's primary practice is Island Hearing & Balance Center in Levittown, New York. Jonathan Harounian is also affiliated with Good Samaritan University Hospital. The medical group on file is Ear, Nose & Throat Associates of Nassau County. Dmand AI also links Jonathan Harounian to 1 more hospital, 4 medical groups, 3 group practices and clinics, 1 physician office and 1 skilled nursing facility, each named with a free account. Jonathan Harounian's employer is on file too: a physical therapy & rehab clinic.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Harounian practices, 8 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Jonathan Harounian's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Jonathan Harounian is licensed in New York.

CMS data shows 194 Medicare services from Jonathan Harounian across 5 procedure codes in 2024, for 120 Medicare patients. Medicare paid $16,320 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Jonathan Harounian in 2024. The largest group is under 65, with 41 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 73% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Harounian's median patient age at 60, with 54% women.

In 2024, Jonathan Harounian wrote 103 Medicare Part D claims for 63 patients. 98% of them were for generic drugs. CMS names the drug for 87 of them, across 1 drug with 11 or more claims each, at $652 in total drug cost. In 2023, CMS named 52 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Jonathan Harounian for performance year 2024, reported as part of a group. Jonathan Harounian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Jonathan Harounian, published from 2015 to 2022. 2019 was the busiest year, with 3. The most frequent topics are Adenoidectomy, Ear Diseases and Postoperative Complications. Jonathan Harounian has published most often in Ear Nose Throat J. Jonathan Harounian's most frequent co-authors are Michele M. Carr, DDS, MD, PhD, Vijay A. Patel, MD and Allan E. Wulc, MD.

CMS Open Payments shows 11 general payments to Jonathan Harounian from 4 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Aerin Medical Inc. paid the most, $254.